Production (Stage)
Applied Therapeutics, Inc.
APLT
$0.4099
-$0.0001-0.02%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -65.35% | 59.12% | 163.95% | 243.10% | 539.19% |
Total Receivables | -- | -- | -8.07% | -8.07% | 116.49% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 486.45% | 28.29% | -5.92% | -14.37% | -84.36% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -45.73% | -19.88% | -26.39% | -32.24% | -20.08% |
Total Current Assets | -64.24% | 53.80% | 135.13% | 197.92% | 419.24% |
|
|||||
Total Current Assets | -64.24% | 53.80% | 135.13% | 197.92% | 419.24% |
Net Property, Plant & Equipment | 719.51% | 524.61% | 284.90% | -67.20% | -55.85% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -62.37% | 58.10% | 135.79% | 192.76% | 404.05% |
|
|||||
Total Accounts Payable | 21.12% | 154.48% | -52.76% | -42.76% | -27.65% |
Total Accrued Expenses | -31.01% | 10.04% | 14.92% | -36.73% | -6.19% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 38.31% | -5.36% | -46.23% | -61.93% | -36.23% |
Total Finance Division Other Current Liabilities | -94.22% | -86.98% | 123.72% | 64.17% | 391.26% |
Total Other Current Liabilities | -94.22% | -86.98% | 123.72% | 64.17% | 391.26% |
Total Current Liabilities | -78.59% | -61.65% | 78.31% | 17.31% | 152.34% |
|
|||||
Total Current Liabilities | -78.59% | -61.65% | 78.31% | 17.31% | 152.34% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 6,397.14% | 6,186.84% | 3,779.55% | -82.35% | -87.97% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -75.89% | -58.76% | 79.01% | 15.44% | 146.33% |
|
|||||
Common Stock & APIC | 2.08% | 39.82% | 48.65% | 61.90% | 74.65% |
Retained Earnings | -7.87% | -22.54% | -43.47% | -41.46% | -53.92% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -45.51% | 432.47% | 153.35% | 1,770.33% | 1,752.60% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -45.51% | 432.47% | 153.35% | 1,770.33% | 1,752.60% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -45.51% | 432.47% | 153.35% | 1,770.33% | 1,752.60% |
|